Press Releases

November 7, 2023 Lupin Receives Tentative Approval from U.S. FDA for Canagliflozin and Metformin Hydrochloride Extended-Release Tablets

November 3, 2023 Lupin and Zydus Sign Licensing Agreement for Co-marketing Saroglitazar Mg, a critical treatment for chronic liver diseases in India

November 2, 2023 Lupin Launches Diazepam Rectal Gel in the United States

November 2, 2023 Lupin Receives Tentative Approval from U.S. FDA for Selexipag for Injection

October 31, 2023 Lupin Receives EIR from U.S. FDA for its Mandideep Unit-2 Manufacturing Facility

October 23, 2023 Lupin Receives Approval from U.S.FDA for Fluconazole Tablets, USP

October 13, 2023 Lupin Receives Tentative Approval from U.S. FDA for Apalutamide Tablets

October 13, 2023 Lupin Receives Tentative Approval from U.S. FDA for Calcium, Magnesium, Potassium, and Sodium Oxybates Oral Solution

October 5, 2023 Lupin Receives Tentative Approval from U.S. FDA for Tolvaptan Tablets